<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27(5)</volume><submitter>Bopp L</submitter><funding>Deutsche Forschungsgemeinschaft</funding><funding>Michael Smith Foundation for Health Research</funding><pubmed_abstract>T cells protect tissues from cancer. Although investigations in mice showed that amino acids (AA) critically regulate T cell immunity, this remains poorly understood in humans. Here, we describe the AA composition of interstitial fluids in keratinocyte-derived skin cancers (KDSCs) and study the effect of AA on T cells using models of primary human cells and tissues. Gln contributed to ∼15% of interstitial AAs and promoted interferon gamma (IFN-γ), but not granzyme B (GzB) expression, in CD8&lt;sup>+&lt;/sup> T cells. Furthermore, the Toll-like receptor 7 agonist imiquimod (IMQ), a common treatment for KDSCs, down-regulated the metabolic gatekeepers &lt;i>c-MYC&lt;/i> and mTORC1, as well as the AA transporter ASCT2 and intracellular Gln, Asn, Ala, and Asp in T cells. Reduced proliferation and IFN-γ exp</pubmed_abstract><journal>iScience</journal><pagination>109767</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11088342</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Glutamine promotes human CD8&lt;sup>+&lt;/sup> T cells and counteracts imiquimod-induced T cell hyporesponsiveness.</pubmed_title><pmcid>PMC11088342</pmcid><pubmed_authors>Brodesser S</pubmed_authors><pubmed_authors>Martinez ML</pubmed_authors><pubmed_authors>Lackmann JW</pubmed_authors><pubmed_authors>Bopp L</pubmed_authors><pubmed_authors>Lukas D</pubmed_authors><pubmed_authors>Arana MH</pubmed_authors><pubmed_authors>Oh JH</pubmed_authors><pubmed_authors>Brachvogel B</pubmed_authors><pubmed_authors>Seitz R</pubmed_authors><pubmed_authors>Neumayer D</pubmed_authors><pubmed_authors>Klapproth H</pubmed_authors><pubmed_authors>Mueller S</pubmed_authors><pubmed_authors>von Stebut E</pubmed_authors><pubmed_authors>Klein Geltink RI</pubmed_authors><pubmed_authors>Schumacher C</pubmed_authors><pubmed_authors>Fabri M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Glutamine promotes human CD8&lt;sup>+&lt;/sup> T cells and counteracts imiquimod-induced T cell hyporesponsiveness.</name><description>T cells protect tissues from cancer. Although investigations in mice showed that amino acids (AA) critically regulate T cell immunity, this remains poorly understood in humans. Here, we describe the AA composition of interstitial fluids in keratinocyte-derived skin cancers (KDSCs) and study the effect of AA on T cells using models of primary human cells and tissues. Gln contributed to ∼15% of interstitial AAs and promoted interferon gamma (IFN-γ), but not granzyme B (GzB) expression, in CD8&lt;sup>+&lt;/sup> T cells. Furthermore, the Toll-like receptor 7 agonist imiquimod (IMQ), a common treatment for KDSCs, down-regulated the metabolic gatekeepers &lt;i>c-MYC&lt;/i> and mTORC1, as well as the AA transporter ASCT2 and intracellular Gln, Asn, Ala, and Asp in T cells. Reduced proliferation and IFN-γ exp</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-06-03T04:21:43.441Z</modification><creation>2026-04-24T03:10:00.176Z</creation></dates><accession>S-EPMC11088342</accession><cross_references><pubmed>38736545</pubmed><doi>10.1016/j.isci.2024.109767</doi></cross_references></HashMap>